论文部分内容阅读
近几年,分子诊断技术的进步使恶性淋巴瘤的分类、分型不断更新,淋巴瘤的治疗也日趋规范合理,近期疗效和远期生存均有了相当大的改善。另外,随着肿瘤基因组学研究的不断深入和精准医学的飞速发展,淋巴瘤的诊断和治疗也开启了个体化诊疗的新篇章。为促进国内各地区淋巴瘤诊治经验交流,展示恶性淋巴瘤临床及基础研究动态,推广规范化的诊疗模式,促进个体化精准医疗的发展,《中国肿瘤临床》2016年第14期针
In recent years, advances in molecular diagnostic techniques make the classification and classification of malignant lymphomas continuously updated, and the treatment of lymphomas has become more standardized and reasonable. Both the short-term efficacy and long-term survival have been greatly improved. In addition, with the continuous research of oncology genomics and the rapid development of precision medicine, the diagnosis and treatment of lymphomas have opened a new chapter of individualized diagnosis and treatment. In order to promote the exchange of experience in the diagnosis and treatment of lymphoma in different regions of China, to show the clinical and basic research trends of malignant lymphoma, to promote the standardized diagnosis and treatment mode and to promote the development of individualized and accurate medical treatment, China Clinic of Clinical Oncology, No.14 2016